LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Reset all filters
01 1LGM Pharma
02 1Aktinos
03 1Apicore
04 1Arch Pharmalabs
05 1Catalent Pharma Solutions
06 1Emcure Pharmaceuticals
07 1Fujifilm Diosynth Biotechnologies
08 1Hetero Drugs
09 1Laurus Labs
10 1Matrix Pharmaceutical Inc
11 2Procos
12 1Raks Pharma
13 1Solara Active Pharma Sciences
14 1Taro Pharmaceutical Industries
15 1Unipex
16 2Viatris
17 1Blank
Reset all filters
01 1France
02 8India
03 2Italy
04 6U.S.A
05 1United Kingdom
06 1Blank
Reset all filters
01 7Active
02 4Inactive
03 8Blank
01 19Blank
Reset all filters
01 19Blank
Reset all filters
01 1WC-0395
02 18Blank
Reset all filters
01 19Blank
Reset all filters
01 114593-862
02 122365-007
03 142385-721
04 146016-2541
05 146016-2542
06 147621-054
07 169988-0032
08 172643-037
09 173223-003
10 184206-0107
11 9Blank
01 19Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-27
Pay. Date : 2016-12-27
DMF Number : 31181
Submission : 2016-12-28
Status : Active
Type : II
NDC Package Code : 47621-054
Start Marketing Date : 2017-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-02-03
Pay. Date : 2015-02-13
DMF Number : 21247
Submission : 2008-01-14
Status : Active
Type : II
NDC Package Code : 46016-2541
Start Marketing Date : 2004-10-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2015-01-29
Pay. Date : 2015-01-19
DMF Number : 22958
Submission : 2009-07-15
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39207
Submission : 2023-12-01
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2024-07-25
Pay. Date : 2024-07-18
DMF Number : 22810
Submission : 2009-06-15
Status : Active
Type : II
NDC Package Code : 72643-037
Start Marketing Date : 2024-03-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

✕ Product Not Available For Sales
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-06
Pay. Date : 2013-11-06
DMF Number : 27331
Submission : 2013-11-05
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2015-10-02
Pay. Date : 2015-07-08
DMF Number : 29408
Submission : 2015-06-26
Status : Active
Type : II
NDC Package Code : 14593-862
Start Marketing Date : 2023-12-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22201
Submission : 2008-11-20
Status : Inactive
Type : II

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7267
Submission : 1987-12-29
Status : Inactive
Type : II

45
PharmaCompass offers a list of Felbamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Felbamate manufacturer or Felbamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Felbamate manufacturer or Felbamate supplier.
PharmaCompass also assists you with knowing the Felbamate API Price utilized in the formulation of products. Felbamate API Price is not always fixed or binding as the Felbamate Price is obtained through a variety of data sources. The Felbamate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Taloxa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Taloxa, including repackagers and relabelers. The FDA regulates Taloxa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Taloxa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Taloxa manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Taloxa supplier is an individual or a company that provides Taloxa active pharmaceutical ingredient (API) or Taloxa finished formulations upon request. The Taloxa suppliers may include Taloxa API manufacturers, exporters, distributors and traders.
click here to find a list of Taloxa suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 16 companies offering Taloxa
Get in contact with the supplier of your choice: